Effects of Dual Task Prioritization Training on Dual Task Walking in Older People

September 26, 2022 updated by: Ray-Yau Wang, National Yang Ming University

Effects of Dual Task Prioritization Training on Dual Task Walking in Older People: A Single-blinded Randomized Controlled Trial

The purpose of this single-blinded three-armed randomized controlled trial is to investigate the effect of different task prioritization during dual task training on dual task performance.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

Introduction: Many activities of daily livings involve performing two tasks simultaneously, i.e. dual tasking. Performing dual task increases the demand on attentional resources, which may further decrease the dual task performance, especially in older adults. According to capacity sharing theory, the two tasks compete and influence with each other due to limited attention and information processing capacity. It has been noted that task prioritization during dual tasking may influence the dual task performance. Previous study indicated that supraposture-focus strategy resulted in better posture and task performance in older people. On the other hand, it is known that dual task training improved dual task performance. However, the effects of applying task prioritization during dual task training have not yet been investigated. Therefore, the purpose of this study is to investigate the effect of different task prioritization during dual task training on dual task performance.

Methods: Participants will be randomized into three groups: posture-focus, supraposture-focus and control group. Participants will receive a total of 12 sessions of cognitive dual task training with different prioritization strategies, i.e. prioritization on posture, cognitive or neither task. Walking and task performance during dual task walking, executive function, and balance performance will be assessed before and after the interventions (pre- and post-test).

Study Type

Interventional

Enrollment (Anticipated)

39

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Taipei, Taiwan, 112
        • Recruiting
        • National Yang Ming Chiao Tung University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

63 years and older (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age ≥ 65 years old
  • MMSE scores > 24

Exclusion Criteria:

  • Unstable health conditions
  • Any neurological, psychological disease or diagnosis of learning disability which interferes the participation in this study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Posture-focus group
Participants will be instructed to pay most attention to practice the posture task during training
All participants will receive cognitive dual task training for 30 min/session, 2-3 sessions/week for 4-6 weeks (a total of 12 sessions). The cognitive dual task training includes 15 min of cognitive task combining with standing task and 15 min of cognitive task combining with walking task. The differences among group are the instructions of task prioritization given by the therapist
Experimental: Supraposture-focus group
Participants will be instructed to pay most attention to practice the cognitive task during training
All participants will receive cognitive dual task training for 30 min/session, 2-3 sessions/week for 4-6 weeks (a total of 12 sessions). The cognitive dual task training includes 15 min of cognitive task combining with standing task and 15 min of cognitive task combining with walking task. The differences among group are the instructions of task prioritization given by the therapist
Active Comparator: Control group
Participants will not be receive any instruction to prioritize either task
All participants will receive cognitive dual task training for 30 min/session, 2-3 sessions/week for 4-6 weeks (a total of 12 sessions). The cognitive dual task training includes 15 min of cognitive task combining with standing task and 15 min of cognitive task combining with walking task. The differences among group are the instructions of task prioritization given by the therapist

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Dual task walking performance assessment- speed (m/s)
Time Frame: Change from baseline dual task walking speed and up to 6 weeks (pre- and post-test)
Using GaitUp system to evaluate gait speed during cognitive and motor dual task walking
Change from baseline dual task walking speed and up to 6 weeks (pre- and post-test)
Dual task walking performance assessment- cadence (steps/min)
Time Frame: Change from baseline dual task walking cadence and up to 6 weeks (pre- and post-test)
Using GaitUp system to evaluate cadence during cognitive and motor dual task walking
Change from baseline dual task walking cadence and up to 6 weeks (pre- and post-test)
Dual task walking performance assessment- stride length variability (CV, %)
Time Frame: Change from baseline dual task walking stride length variability and up to 6 weeks (pre- and post-test)
Using GaitUp system to evaluate stride length variability during cognitive and motor dual task walking
Change from baseline dual task walking stride length variability and up to 6 weeks (pre- and post-test)
Dual task walking performance assessment- stride time variability (CV, %)
Time Frame: Change from baseline dual task walking stride time variability and up to 6 weeks (pre- and post-test)
Using GaitUp system to evaluate stride time variability during cognitive and motor dual task walking
Change from baseline dual task walking stride time variability and up to 6 weeks (pre- and post-test)
Rate of dual task cost- gait speed (%)
Time Frame: Change from baseline dual task cost and up to 6 weeks (pre- and post-test)
Using the dual and single task walking speed to calculate the dual task cost of gait speed
Change from baseline dual task cost and up to 6 weeks (pre- and post-test)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Trail Making Test
Time Frame: Change from baseline Trail Making Test and up to 6 weeks (pre- and post-test)
Use Trail Making Test (TMT)-Chinese version to indicate executive function. The duration for completing the test will be measured, and the shorter duration means the better executive function.
Change from baseline Trail Making Test and up to 6 weeks (pre- and post-test)
Berg Balance Scale
Time Frame: Change from baseline Berg Balance Scale and up to 6 weeks (pre- and post-test)
Use Berg Balance Scale (BBS) to assess balance performance. Berg balance scale scoring ranges from 0 to 56. The higher scores indicate better balance performance.
Change from baseline Berg Balance Scale and up to 6 weeks (pre- and post-test)
Single task walking performance assessment- speed (m/s)
Time Frame: Change from baseline single task walking speed and up to 6 weeks (pre- and post-test)
Using GaitUp system to evaluate gait speed during single walking
Change from baseline single task walking speed and up to 6 weeks (pre- and post-test)
Single task walking performance assessment- cadence (steps/min)
Time Frame: Change from baseline single task walking cadence and up to 6 weeks (pre- and post-test)
Using GaitUp system to evaluate cadence during single walking
Change from baseline single task walking cadence and up to 6 weeks (pre- and post-test)
Single task walking performance assessment- stride length variability (CV, %)
Time Frame: Change from baseline single task walking stride length variability and up to 6 weeks (pre- and post-test)
Using GaitUp system to evaluate stride length variability during single walking
Change from baseline single task walking stride length variability and up to 6 weeks (pre- and post-test)
Single task walking performance assessment- stride time variability (CV, %)
Time Frame: Change from baseline dual task walking stride time variability and up to 6 weeks (pre- and post-test)
Using GaitUp system to evaluate stride time variability during single walking
Change from baseline dual task walking stride time variability and up to 6 weeks (pre- and post-test)
Cognitive dual task walking performance assessment- correct number (times)
Time Frame: Change from baseline cognitive dual task walking performance and up to 6 weeks (pre- and post-test)
The number of the correct answer for serially subtracting "7" from a predefined 3-digit number during cognitive dual task walking task will be recorded.
Change from baseline cognitive dual task walking performance and up to 6 weeks (pre- and post-test)
Motor dual task walking performance assessment- number of go (pieces)
Time Frame: Change from baseline motor dual task walking performance and up to 6 weeks (pre- and post-test)
The number of successfully transferred go pieces from one side to another during motor dual task walking task will be recorded.
Change from baseline motor dual task walking performance and up to 6 weeks (pre- and post-test)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ray-Yau Wang, PhD, National Yang Ming Chiao Tung University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 25, 2022

Primary Completion (Anticipated)

June 1, 2023

Study Completion (Anticipated)

June 1, 2023

Study Registration Dates

First Submitted

April 12, 2022

First Submitted That Met QC Criteria

May 4, 2022

First Posted (Actual)

May 10, 2022

Study Record Updates

Last Update Posted (Actual)

September 28, 2022

Last Update Submitted That Met QC Criteria

September 26, 2022

Last Verified

September 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on Dual task training

3
Subscribe